JPMorgan Chase & Co’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $51.5K | Buy |
|
|||||
|
2025
Q2 | $638 | Sell |
|
|||||
|
2025
Q1 | $66.9K | Sell |
|
|||||
|
2024
Q4 | $836K | Buy |
|
|||||
|
2024
Q3 | $332 | Hold |
|
|||||
|
2024
Q2 | $343 | Hold |
|
|||||
|
2024
Q1 | $613 | Hold |
|
|||||
|
2023
Q4 | $436 | Sell |
|
|||||
|
2023
Q3 | $2.23K | Hold |
|
|||||
|
2023
Q2 | $2.98K | Hold |
|
|||||
|
2023
Q1 | $3K | Hold |
|
|||||
|
2022
Q4 | $3K | Sell |
|
|||||
|
2022
Q3 | $6K | Buy |
|
|||||
|
2022
Q2 | $5K | Sell |
|
|||||
|
2022
Q1 | $814K | Sell |
|
|||||
|
2021
Q4 | $1.33M | Sell |
|
|||||
|
2021
Q3 | $1.63M | Sell |
|
|||||
|
2021
Q2 | $2.16M | Buy |
|
|||||
|
2021
Q1 | $559K | Sell |
|
|||||
|
2020
Q4 | $528K | Sell |
|
|||||
|
2020
Q3 | $618K | Sell |
|
|||||
|
2020
Q2 | $828K | Sell |
|
|||||
|
2020
Q1 | $1.35M | Sell |
|
|||||
|
2019
Q4 | $3.07M | Buy |
|
|||||
|
2019
Q3 | $991K | Buy |
|
|||||
|
2019
Q2 | $1.35M | Sell |
|
|||||
|
2019
Q1 | $1.45M | Sell |
|
|||||
|
2018
Q4 | $2.16M | Sell |
|
|||||
|
2018
Q3 | $2.79M | Buy |
|
|||||
|
2018
Q2 | $3.2M | Sell |
|
|||||
|
2018
Q1 | $5.72M | Sell |
|
|||||
|
2017
Q4 | $5.14M | Buy |
|
|||||
|
2017
Q3 | $4.31M | Sell |
|
|||||
|
2017
Q2 | $3.76M | Buy |
|
|||||
|
2017
Q1 | $3.21M | Buy |
|
|||||
|
2016
Q4 | $313K | Buy |
|